+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Hematologic Malignancy Drug"

Hematologic Malignancies Market Size, Share & Trends Analysis Report By Disease (Leukemia, Lymphoma), By Therapy (Chemotherapy, Immunotherapy), By End Use, By Region, And Segment Forecasts, 2024 - 2030 - Product Thumbnail Image

Hematologic Malignancies Market Size, Share & Trends Analysis Report By Disease (Leukemia, Lymphoma), By Therapy (Chemotherapy, Immunotherapy), By End Use, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • August 2024
  • 120 Pages
  • Global
From
Hematologic Malignancies Market Report by Type, Therapy, End User, and Region 2024-2032 - Product Thumbnail Image

Hematologic Malignancies Market Report by Type, Therapy, End User, and Region 2024-2032

  • Report
  • August 2024
  • 136 Pages
  • Global
From
Hematologic Malignancies Testing Market by Product, Technology, Disease Type, End-Users - Global Forecast 2025-2030 - Product Thumbnail Image

Hematologic Malignancies Testing Market by Product, Technology, Disease Type, End-Users - Global Forecast 2025-2030

  • Report
  • October 2024
  • 194 Pages
  • Global
From
Hematologic Malignancies Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Thumbnail Image

Hematologic Malignancies Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • February 2024
  • 111 Pages
  • Global
From
  • 4 Results (Page 1 of 1)
Loading Indicator

The Hematologic Malignancy Drug market is a subset of the Oncology Drugs market, which focuses on the treatment of blood cancers such as leukemia, lymphoma, and myeloma. These drugs are used to treat both acute and chronic forms of these diseases, and can be administered orally, intravenously, or subcutaneously. Common drugs used in this market include chemotherapy, targeted therapy, immunotherapy, and stem cell transplantation. The Hematologic Malignancy Drug market is highly competitive, with many large pharmaceutical companies vying for market share. Companies in this market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Celgene, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more